l.ibarra
TL2 Regular · Monterrey, MX
Interested in what the evidence says versus what the marketing says. Reads in two languages, posts in one.
Joined 6 July 2025 · last posted 2d · groups: translators
74 posts, newest first. Showing up to 150.
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #91 · Practice › Interactions · 26 Jul 2026 · 2 likes On post #87 — agreed on the reasoning, with one qualification. Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side…
-
What I would want from a home test that does not exist yet Replied, post #47 · Analytics › Home & field testing · 24 Jul 2026 · 0 likes Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #102 · Evidence › Journal club · 22 Jul 2026 · 0 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #72 · Practice › Interactions · 21 Jul 2026 · 0 likes This follows post #69 rather than contradicting it. Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes…
-
Aggregate verification data across the directory, with caveats Replied, post #55 · Sourcing › Independent verification · 18 Jul 2026 · 0 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #62 · Outcomes › Body composition · 17 Jul 2026 · 32 likes Precision versus accuracy: the precision you need depends on what question you are answering. "Am I losing fat?" requires less precision than "Is my lean mass…
-
Here for the analytics and not much else Replied, post #43 · Lounge › Introductions · 16 Jul 2026 · 0 likes Welcome: the response to introductions is usually welcome. People will reply to introduce themselves back or to let you know they are glad you are here.
-
Revisiting: Mobile reading experience on long topics Replied, post #14 · Meta › Site feedback · 14 Jul 2026 · 0 likes Community norms: if you think a norm has drifted or is not being followed consistently, raising it here can prompt discussion and realignment.
-
Selection into a registry and what it does to the estimate — a second dataset Replied, post #14 · Evidence › Study critique · 11 Jul 2026 · 8 likes Criticise the method, not the author: a paper with a weak design is not a bad paper by someone with bad intentions. It is a paper that answers a limited question.…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #76 · Sourcing › Independent verification · 9 Jul 2026 · 27 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #16 · Practice › Dosing & titration · 7 Jul 2026 · 26 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #66 · Outcomes › Progress reports · 27 Jun 2026 · 33 likes Picking up post #63: that is the part I would want checked first. Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to…
-
Run-in periods and the population they select Replied, post #142 · Evidence › Trials · 23 Jun 2026 · 23 likes Picking up post #139: that is the part I would want checked first. Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method…
-
Journal club: what we got wrong in an earlier session Replied, post #19 · Evidence › Journal club · 21 Jun 2026 · 0 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #79 · Safety › Contraindications · 19 Jun 2026 · 1 like On post #75 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #43 · Practice › Administration · 17 Jun 2026 · 15 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Journal club: what we got wrong in an earlier session Replied, post #9 · Evidence › Journal club · 17 Jun 2026 · 16 likes Picking up post #6: that is the part I would want checked first. Session format: read the paper before posting. The discussion is much better when everyone has. Start…
-
Transporting a vial for a weekend away — a second dataset Replied, post #83 · Practice › Storage & stability · 15 Jun 2026 · 22 likes Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know whether it has been sitting for weeks or days, the…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #23 · Compounds › Oral incretins · 1 Jun 2026 · 1 like Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is comparing apples to a different fruit. The oral bioavailability is low…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #7 · Practice › Storage & stability · 29 May 2026 · 8 likes Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage protein structure. Whether your specific solution tolerates it depends on the…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #60 · Compounds › Repair & healing peptides · 25 May 2026 · 0 likes post #59 is right about the mechanism and I think understates the practical bit. Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass (≈1419.5…
-
Reused chromatograms across lots: how to spot it — what changed since Replied, post #39 · Analytics › COA interpretation · 16 May 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
A site rotation scheme that is easy enough to actually follow Replied, post #58 · Practice › Administration · 8 May 2026 · 6 likes This follows post #55 rather than contradicting it. Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous tissue…
-
Personal import allowances, compared — a second dataset Replied, post #115 · Access › International · 2 May 2026 · 8 likes Worth separating two things that post #111 runs together. Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on…
-
A 10 mg vial reconstituted three different ways, compared Replied, post #16 · Practice › Reconstitution · 24 Apr 2026 · 30 likes Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
-
Second pass at: The storage lookup and where its data comes from Replied, post #9 · Data & Tools › Calculators · 24 Apr 2026 · 16 likes This follows post #6 rather than contradicting it. Titration planning: a calculator that shows you the escalation schedule for different starting and ending doses can…
-
The anatomy of a question that gets answered within an hour Replied, post #22 · Start Here › How to Ask · 19 Apr 2026 · 31 likes Lab result questions: state the result, the reference interval, and what else is on the same panel. A single flag on a single draw is usually uninformative without…
-
Type 2 diabetes and the largest part of the evidence base Replied, post #73 · Clinical › Comorbidities · 18 Apr 2026 · 3 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Spike-and-recover accuracy for a peptide assay Replied, post #83 · Analytics › Method validation · 9 Apr 2026 · 0 likes This follows post #80 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Follow-up: State-level differences that actually matter Replied, post #17 · Regional › North America · 4 Apr 2026 · 31 likes post #16 is right about the mechanism and I think understates the practical bit. Regional variation in North America: access differs substantially by US state and…
-
Why the timeline is on the right and not the left — what changed since Replied, post #8 · Meta › Site feedback · 18 Mar 2026 · 6 likes Search and findability: if you searched for something and did not find it, report what you searched for and what you expected to find. That helps improve indexing and…
-
Preprint servers and what screening they do Replied, post #75 · Evidence › Preprints · 3 Mar 2026 · 24 likes What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors found in peer review, and sometimes report…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #58 · Clinical › Bloodwork · 2 Mar 2026 · 7 likes A single value outside interval: usually uninformative on a single draw. What makes a result interesting: a trend across multiple draws, a magnitude well beyond the…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #40 · Compounds › Semaglutide · 2 Dec 2025 · 15 likes Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach empties it feeds less food into the intestines at a time,…
-
Documentation that materially improves an appeal's chances Replied, post #84 · Access › Insurance & coverage · 30 Nov 2025 · 31 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
-
An inter-laboratory comparison on one lot, tabulated — what changed since Replied, post #20 · Analytics › Method validation · 28 Nov 2025 · 5 likes Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance.
-
MHRA statements, read directly Replied, post #37 · Regional › UK & Ireland · 24 Nov 2025 · 1 like post #36 answers the question as asked. The question underneath it is different. Cross-border arrangements: some people source from other EU countries. Rules on import…
-
Why semaglutide's albumin binding is the whole reason weekly dosing works Replied, post #2 · Compounds › Semaglutide · 15 Nov 2025 · 5 likes I read the opening post twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #57 · Compounds › Tirzepatide · 13 Nov 2025 · 0 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
-
Publishing an inconvenient result: a case study — the long version Replied, post #29 · Sourcing › Independent verification · 6 Nov 2025 · 19 likes On post #25 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #55 · Safety › Adverse events · 25 Oct 2025 · 2 likes Psychological adverse events: mood changes, anxiety, or suicidal ideation warrant discussion with a mental health professional. These are rare but real.
-
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #50 · Compounds › Tirzepatide · 20 Oct 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #4 · Pharmacology › Pharmacokinetics · 14 Oct 2025 · 11 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
New subcategory: rationale and scope Replied, post #7 · Meta › Announcements · 12 Oct 2025 · 33 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #62 · Practice › Dosing & titration · 11 Oct 2025 · 16 likes This follows post #59 rather than contradicting it. The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #79 · Evidence › Preprints · 2 Oct 2025 · 19 likes What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors found in peer review, and sometimes report…
-
Documentation that materially improves an appeal's chances Started this topic · Access › Insurance & coverage · 11 Sep 2025 · 39 likes Documentation that materially improves an appeal's chances — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork…
-
Cost per delivered dose, which is the number that matters Replied, post #6 · Access › Pricing · 6 Sep 2025 · 0 likes Picking up post #3: that is the part I would want checked first. Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That…
-
High-resolution MS on aggregates and what it can see Replied, post #57 · Analytics › Mass spectrometry · 1 Sep 2025 · 0 likes Worth separating two things that post #53 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Revisiting: German, French and Dutch differences, compared Replied, post #65 · Regional › European Union · 29 Aug 2025 · 9 likes Italy: AIFA controls reimbursement through a note system. Weight-management indications have not attracted public reimbursement. Regional health authorities add further…
-
A ten-fold dose error caught before injection — one year on Replied, post #139 · Devices › Syringes & needles · 5 Aug 2025 · 5 likes This follows post #136 rather than contradicting it. Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume loss to the hub).…
-
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #26 · Analytics › COA interpretation · 25 Jul 2025 · 2 likes Coming back to post #24, because the follow-up matters more than the original answer. Reading old certificates: if a certificate is dated years ago, the lot it…
-
Reading a supplier's product description as a marketing document Replied, post #36 · Compounds › Other compounds · 22 Jun 2025 · 0 likes Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell compounds that are genuinely novel and difficult to obtain…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #55 · Outcomes › Progress reports · 21 May 2025 · 0 likes Coming back to post #53, because the follow-up matters more than the original answer. Measurement noise: day-to-day body mass varies by more than a kilogram on…
-
Telehealth prescribing models in the US Replied, post #100 · Regional › North America · 17 May 2025 · 7 likes Worth separating two things that post #96 runs together. Private insurance gaps: some people have private insurance but medication is not covered. Manufacturer…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #46 · Practice › Reconstitution · 2 May 2025 · 0 likes post #45 is right about the mechanism and I think understates the practical bit. Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #19 · Evidence › Trials · 30 Apr 2025 · 0 likes Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #106 · Compounds › Cagrilintide & amylin analogues · 28 Apr 2025 · 2 likes The dosing interval: cagrilintide's half-life is roughly 7 to 8 days, suitable for weekly dosing. The pharmacokinetics are the reason the dosing schedule makes sense.
-
Asking about a compound your prescriber has not heard of Replied, post #16 · Clinical › Prescriber conversations · 13 Apr 2025 · 0 likes Worth separating two things that post #12 runs together. Preparing for an appointment: bring recent bloodwork, a list of current medications with doses and timing, and…
-
Retatrutide dose escalation in the published trials Replied, post #53 · Compounds › Retatrutide · 26 Mar 2025 · 31 likes Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not assume a theoretical mass. The theoretical mass is not published in…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #2 · Evidence › Trials · 26 Mar 2025 · 9 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #9 · Devices › Cold chain · 17 Mar 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Consistent declarations and why they matter more than clever ones Replied, post #136 · Sourcing › Logistics · 6 Mar 2025 · 0 likes Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing a carrier matters if you are shipping expensive material.
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #35 · Practice › Reconstitution · 20 Feb 2025 · 21 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #107 · Access › Insurance & coverage · 6 Jan 2025 · 0 likes Picking up post #104: that is the part I would want checked first. Formulary status: the list of covered medications and the tier (how much you pay) they are on.…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #13 · Compounds › Semaglutide · 31 Dec 2024 · 0 likes Coming back to post #11, because the follow-up matters more than the original answer. On alcohol: the labelling does not contraindicate it, but it raises gastric…
-
Second pass at: Albumin binding and how it produces a long half-life Replied, post #8 · Pharmacology › Pharmacokinetics · 19 Dec 2024 · 1 like I read post #6 twice before replying, because I had assumed the opposite. SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino) caprylate…
-
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #31 · Meta › Wiki maintenance · 9 Nov 2024 · 0 likes I read post #29 twice before replying, because I had assumed the opposite. Redundancy: if two maintained pages cover largely the same ground, consolidation might…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #15 · Wellbeing › Mental health · 8 Nov 2024 · 10 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Tirzepatide storage and stability: what is published versus what is assumed — does this… Replied, post #6 · Compounds › Tirzepatide · 26 Oct 2024 · 29 likes This follows post #3 rather than contradicting it. The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is a…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #53 · Practice › Administration · 24 Sep 2024 · 2 likes Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle for injection reduces tissue drag and can decrease…
-
Gallbladder disease risk with rapid weight loss Replied, post #8 · Clinical › Comorbidities · 10 Sep 2024 · 2 likes Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit appears to be additive to other renal-protective agents,…
-
Correlation in a self-tracked dataset: what it can support Replied, post #126 · Research Methods › Statistics · 25 Aug 2024 · 0 likes Relative risk and odds ratios: both compare the rate in one group to the rate in another. Relative risk is easier to understand. Odds ratios are standard in many…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #41 · Clinical › Prescriber conversations · 20 Aug 2024 · 5 likes post #40 answers the question as asked. The question underneath it is different. Questions about dose: asking "how will we determine whether this dose is working for…